Menu Search
Equities

Netcare Ltd

NH7:STU

Netcare Ltd

Actions
Health CareHealth Care Providers
  • Price (EUR)0.498
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-27.30%
  • Beta--
Data delayed at least 15 minutes, as of Apr 25 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Netcare Limited is a South Africa-based provider of private healthcare services. The Company's business divisions include Netcare Hospitals, Netcare Medicross, Netcare Akeso, Netcare 911 and National Renal Care. Its services include Netcare appointmed, Netcare Cancer Care, Netcare Family Connect Line, Netcare Occupational Health and Netcare Pharmacy. The Company's segments include hospital and emergency services and primary care. The hospital and emergency services segment consists of hospital and pharmacy operations, which includes its private acute hospital network and day clinics, and non-acute services, which provides emergency services, operation of private mental health clinics, cancer care, diagnostic services and the sale of healthcare products and vouchers. The primary care segment provides primary healthcare services, employee health and wellness services and administrative services to medical and dental practices. Its NetcarePlus product offers private healthcare products.

  • Revenue in ZAR (TTM)23.70bn
  • Net income in ZAR1.27bn
  • Incorporated1996
  • Employees20.37k
  • Location
    Netcare Ltd76 Maude Street, corner West StreetSANDTON 2196South AfricaZAF
  • Phone+27 113010000
  • Fax+27 113010499
  • Websitehttp://www.netcare.co.za/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.